loader
Please Wait
Applying Filters...

Details of Johnson & Johnson's U.S. FDA Inspections. Original Data: FDA Inspection Database

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Janssen Ortho L.L.C.

02 7Janssen Ortho LLC

03 3Janssen Pharmaceutica NV

04 1Janssen Pharmaceutical Inc

05 3Janssen Pharmaceutical, Ltd.

06 15Janssen Pharmaceuticals, Inc.

07 1Johnson & Johnson Consumer Inc

08 2Tasmanian Alkaloids Pty. Ltd.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

FDA Audited

USA
Boulder Peptide 2024
Not Confirmed
arrow

FDA Audited

USA
arrow
Boulder Peptide 2024
Not Confirmed

Johnson & Johnson Innovative Medicine

City : Raritan

State : NJ

Country/Area : US

Zip : 08869-1425

District : NWJ

Center : CDER

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2012-06-19

blank

02

FDA Audited

USA
Boulder Peptide 2024
Not Confirmed
arrow

FDA Audited

USA
arrow
Boulder Peptide 2024
Not Confirmed

Johnson & Johnson Innovative Medicine

City : Athens

State : GA

Country/Area : US

Zip : 30601-1645

District : ATL

Center : CDRH

Project Area : Compliance: Devices

District Decision : No Action Indicated

Inspection End Date : 2009-03-27

blank

03

FDA Audited

USA
Boulder Peptide 2024
Not Confirmed
arrow

FDA Audited

USA
arrow
Boulder Peptide 2024
Not Confirmed

Johnson & Johnson Innovative Medicine

City : Titusville

State : NJ

Country/Area : US

Zip : 08560-1503

District : NWJ

Center : CDER

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2012-06-28

blank

04

FDA Audited

USA
Boulder Peptide 2024
Not Confirmed
arrow

FDA Audited

USA
arrow
Boulder Peptide 2024
Not Confirmed

Johnson & Johnson Innovative Medicine

City : Athens

State : GA

Country/Area : US

Zip : 30601-1645

District : ATL

Center : CDRH

Project Area : Compliance: Devices

District Decision : No Action Indicated

Inspection End Date : 2011-02-18

blank

05

FDA Audited

USA
Boulder Peptide 2024
Not Confirmed
arrow

FDA Audited

USA
arrow
Boulder Peptide 2024
Not Confirmed

Johnson & Johnson Innovative Medicine

City : Raritan

State : NJ

Country/Area : US

Zip : 08869-1425

District : NWJ

Center : CDER

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2009-01-15

blank

06

FDA Audited

USA
Boulder Peptide 2024
Not Confirmed
arrow

FDA Audited

USA
arrow
Boulder Peptide 2024
Not Confirmed

Johnson & Johnson Innovative Medicine

City : Titusville

State : NJ

Country/Area : US

Zip : 08560-1503

District : NWJ

Center : CDER

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2009-04-09

blank

07

FDA Audited

USA
Boulder Peptide 2024
Not Confirmed
arrow

FDA Audited

USA
arrow
Boulder Peptide 2024
Not Confirmed

Johnson & Johnson Innovative Medicine

City : Raritan

State : NJ

Country/Area : US

Zip : 08869-1425

District : NWJ

Center : CDER

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2010-08-06

blank

08

FDA Audited

USA
Boulder Peptide 2024
Not Confirmed
arrow

FDA Audited

USA
arrow
Boulder Peptide 2024
Not Confirmed

Johnson & Johnson Innovative Medicine

City : Titusville

State : NJ

Country/Area : US

Zip : 08560-1503

District : NWJ

Center : CVM

Project Area : Pre-Approval Eval. of Animal Dru...

District Decision : Voluntary Action Indicated

Inspection End Date : 2010-12-09

blank

09

FDA Audited

USA
Boulder Peptide 2024
Not Confirmed
arrow

FDA Audited

USA
arrow
Boulder Peptide 2024
Not Confirmed

Johnson & Johnson Innovative Medicine

City : Titusville

State : NJ

Country/Area : US

Zip : 08560-1503

District : NWJ

Center : CDER

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2011-06-01

blank

10

FDA Audited

USA
Boulder Peptide 2024
Not Confirmed
arrow

FDA Audited

USA
arrow
Boulder Peptide 2024
Not Confirmed

Johnson & Johnson Innovative Medicine

City : Raritan

State : NJ

Country/Area : US

Zip : 08869-1425

District : NWJ

Center : CDER

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2011-08-22

blank
Contact Johnson & Johnson and get a quotation

Johnson & Johnson is a supplier offers 2 products (APIs, Excipients or Intermediates).

Find a price of Nicotine bulk with DMF offered by Johnson & Johnson

Find a price of Naloxone Hydrochloride bulk offered by Johnson & Johnson